Jennifer Hudson

December 03, 2015 | New York Law Journal

With last week's news that pharmaceutical giants Pfizer Inc. and Allergan plc will join together in a tax inversion valued at $160 billion, 2015 appears to be the year of the deal. The transaction brings total M&A value to $3.82 trillion for the year to date—4.3 percent higher than the record set in 2007, according to Mergermarket data.

By Jennifer Hudson

6 minute read

December 02, 2015 | New York Law Journal

With last week's news that pharmaceutical giants Pfizer Inc. and Allergan plc will join together in a tax inversion valued at $160 billion, 2015 appears to be the year of the deal. The transaction brings total M&A value to $3.82 trillion for the year to date—4.3 percent higher than the record set in 2007, according to Mergermarket data.

By Jennifer Hudson

6 minute read